MedPath

The effects of coenzyme Q10 supplementation on burn patients

Phase 3
Recruiting
Conditions
burns.
Burn of unspecified body region, unspecified degree
T30.0
Registration Number
IRCT20201129049534N3
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 65-18 years
Accept informed consent by the patient or his mobile
Gastrointestinal tract with normal function
Has a burn above 20%
Proper fluid recovery in the first 24 hours and hemodynamic stability after 48 hours

Exclusion Criteria

• Patients who are hospitalized for less than 48 hours or do not have stable conditions to start oral or tube feeding.
• Dissatisfaction of the patient or family.
• Patients with cancer undergoing chemotherapy and cisplatin.
Patients receiving warfarin.
• Pregnancy
Severe and progressive septic shock or sepsis
Hypovolemic shock in the first 48 hours
Patients who are expected to die within one week of admission.
• Patients with a history of certain diseases such as congenital and immune disorders, cirrhosis and pancreatitis.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath